A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, called aortic valve stenosis, progresses differently in males and females.
Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...
Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...
Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...
A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...
Having any sleep disorder is associated with an increased risk for aortic stenosis, according to an analysis of data from two large sets of electronic health records.
Healthcare Asia Magazine on MSN4d
What factors drive the cardiac valve repair devices market in MEA?Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare ...
Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...
surgical director of the Aortic Institute at Yale New Haven Health Heart & Vascular Center. A typical valve problem called ...
An Infirmary Health doctor has been the first person to perform a TriClip G4 procedure in Mobile successfully and one of the ...
He reported that both patients who underwent the procedure had their mitral regurgitation eliminated ... Vascular Institute ...
The following is a summary of "Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback